Molecular Brain operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. The benefits of single-blind peer-review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.
Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.
We feel that high-quality data should be published promptly, without unnecessary delay. In our experience, reviewers sometimes request additional time-consuming experiments, although the data are already valid and ready for publication. If a manuscript lacks necessary experiments or controls in order to support its conclusions, it will be returned to the authors so they are able to take the time they need to re-visit their data outside of Molecular Brain’s submission system.
Molecular Brain is affiliated with the Association for the Study of Neurons and Disease (AND).
2017 Journal Metrics
32.8 days to first decision for received manuscripts only
30.7 days to first decision for all manuscripts
97.5 days from submission to acceptance
15.4 days from acceptance to publication
388 Altmetric mentions
Molecular Brain has partnered with Publons to give you official recognition for your contribution to peer review. Create a free profile to have your reviews automatically added.